53716-44-2|Rociverine|1-(diethylamino)propan-2-yl 1-hydroxy-[1,1'-bi(cyclohexane)]-2-carboxylate|-范德生物科技公司

Rociverine

NMR下载 COA and HPLC MSDS下载
names：
1-(diethylamino)propan-2-yl 1-hydroxy-[1,1'-bi(cyclohexane)]-2-carboxylate
CAS号：
53716-44-2
MDL Number：
MF(分子式)： C20H37NO3 MW(分子量)： 339.52
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	1-(diethylamino)propan-2-yl 1-hydroxy-[1,1'-bi(cyclohexane)]-2-carboxylate
英文别名	Rociverine; Rociverinum;
CAS号	53716-44-2
Inchi	InChI=1S/C20H37NO3/c1-4-21(5-2)15-16(3)24-19(22)18-13-9-10-14-20(18,23)17-11-7-6-8-12-17/h16-18,23H,4-15H2,1-3H3
InchiKey	XPYLKZZOBVLVHB-UHFFFAOYSA-N
分子式 Formula	C20H37NO3
分子量 Molecular Weight	339.52
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Rociverine(CAS:53716-44-2):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Rociverine is an anticholinergic agent that is used as a smooth muscle relaxant.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Cromi A, Ghezzi F, Agosti M, Uccella S, Piazza N, Serati M, Bolis P. Use of an antispasmodic (rociverine) to shorten the length of labor: a randomized, placebo-controlled trial. Acta Obstet Gynecol Scand. 2011 Dec;90(12):1371-8. doi: 10.1111/j.1600-0412.2011.01265.x. Epub 2011 Oct 1[1]PubMed PMID: 21880029.

[2]Daccó L, Intrieri L. Rociverine for nocturia in the elderly. Clin Ther. 1986;8(2):170-4. PubMed PMID: 3698063.

[3] Hoti E, Censi R, Ricciutelli M, Malaj L, Barboni L, Martelli S, Valleri M, Di Martino P. Validation of an HPLC-MS method for rociverine tablet dissolution analysis. J Pharm Biomed Anal. 2008 Jun 9;47(2):422-8. doi: 10.1016/j.jpba.2008.01.009. Epub 2008 Jan 16. PubMed PMID: 18295427.

[4] Subissi A, Maggi CA, Meli A. Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia. Jpn J Pharmacol. 1986 Oct;42(2):153-7. PubMed PMID: 3540391.

[5] D'Agostino G, Zonta F, Santagostino Barbone MG, Grana E, Brunori P, Subissi A. Mechanism of smooth muscle relaxation by rociverine. Arzneimittelforschung. 1984;34(5):584-9. PubMed PMID: 6540576.

6: Petrillo M, Lazzaroni M, Saponati G, Bianchi Porro G. The use of rociverine as premedication for endoscopy of the upper gastro-intestinal tract: a double-blind controlled clinical trial. Curr Med Res Opin. 1980;7(2):73-6. PubMed PMID: 7002483.7: Schiantarelli P, Murmann W. Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study. Arzneimittelforschung. 1980;30(7):1102-9. PubMed PMID: 7191292.8: Schiantarelli P, Murmann W, Magi S. Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions. Arzneimittelforschung. 1979;29(5):760-5. PubMed PMID: 582975.9: Menicagli S, Lippi A, Criscuoli M, Gervasi PG. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Biochem Pharmacol. 1993 Mar 9;45(5):1097-105. PubMed PMID: 8461039.10: Pardini M, Saponati G. Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma. Pharmatherapeutica. 1983;3(7):445-50. PubMed PMID: 6669589.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开